日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

头颈部复发性鳞状细胞癌患者挽救性切除术后辅助使用纳武利尤单抗的II期临床试验

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-4554
Leddon, Jennifer L; Gulati, Shuchi; Haque, Sulsal; Allen, Casey; Palackdharry, Sarah; Mathews, Maria; Kurtzweil, Nicky; Riaz, Muhammed Kashif; Takiar, Vinita; Nagasaka, Misako; Patil, Yash; Zender, Chad; Tang, Alice; Cervenka, Brian; McGrath, Julie; Korn, W Michael; Hinrichs, Benjamin H; Jandarov, Roman; Harun, Nusrat; Sukari, Ammar; Wise-Draper, Trisha M
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma

挽救性手术时发现的高危病理特征预示着头颈部鳞状细胞癌患者在接受根治性治疗后生存率较低

期刊:Oral Oncology
影响因子:3.9
doi:10.1016/j.oraloncology.2018.11.010
Haque, Sulsal; Karivedu, Vidhya; Riaz, Muhammed K; Choi, David; Roof, Logan; Hassan, Sarah Z; Zhu, Zheng; Jandarov, Roman; Takiar, Vinita; Tang, Alice; Wise-Draper, Trisha
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy

帕博利珠单抗在头颈部鳞状细胞癌治疗中的应用概况：设计开发及在治疗中的地位

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S119537
Haque, Sulsal; Yellu, Mahender; Randhawa, Jaskirat; Hashemi-Sadraei, Nooshin
细胞生物学
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

Transforming growth factor-β: A therapeutic target for cancer

转化生长因子-β：癌症治疗靶点

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2017.1327107
Haque, Sulsal; Morris, John C
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

Pulmonary metastases in pancreatic cancer, is there a survival influence?

胰腺癌肺转移是否会影响生存率？

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.3978/j.issn.2078-6891.2014.114
Deeb, Ayham; Haque, Sulsal-Ul; Olowokure, Olugbenga
胰腺癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

Bilateral above knee amputations after prolonged exposure to sorafenib and trebananib

长期服用索拉非尼和曲巴那尼后，双侧膝上截肢

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.3978/j.issn.2078-6891.2014.049
Haque, Sulsal; Choe, Kyuran; Olowokure, Olugbenga
发表日期：2014
文献求助 收藏